/DISCLAIMER · RESEARCH_COMPOUND

This page is reference information only. Most compounds described here are research chemicals, not FDA-approved medications. MyTRT does not sell, recommend, or endorse the use of these substances. Always consult a qualified physician.

/THYMOSIN_ALPHA_1
Peptide

Thymosin Alpha 1

Immunomodulatory Peptide

/HALF_LIFE
2 hours (approx.)
/DELIVERY
Subcutaneous injection

/WHAT_IT_IS

Thymosin Alpha 1 is a naturally occurring peptide fragment derived from prothymosin alpha, known for its immune-boosting properties.

/USAGE

Used in research related to immune enhancement, chronic infections, and adjunctive cancer therapy. Shown to increase T-cell function.

/MECHANISM_OF_ACTION

Enhances T-cell maturation and function, modulates cytokine production, and improves the innate immune response.

Reported Benefits

  • +Immune system support
  • +Antiviral and antibacterial effects
  • +Potential anti-tumor activity
  • +Improved vaccine response

Reported Side Effects

  • Mild injection site reactions
  • Fatigue
  • Irritability (rare)

/STACKED_WITH

BPC-157TB-500Interferon alpha (in clinical settings)

/RESEARCH_NOTES

Frequently studied in hepatitis, HIV, and immunocompromised patient models. Also explored for use during pandemics.

/REFERENCE

https://pubmed.ncbi.nlm.nih.gov/27450734/

/RELATED

/TRACK_THIS

Browse all 89 in the app.

MyTRT's in-app library has the same 89 peptide entries plus dosing notes, stack builders, and the ability to log them alongside your TRT protocol.

Last reviewed: 2026-06-04 · Reference only. Not medical advice. Consult a qualified physician.